PARTNERSHIP OPPORTUNITIES

As the only event laser-focused on raw materials for cell and gene therapy, the 2nd Raw Materials for Cell & Gene Therapy Summit offers an unmatched platform for suppliers, CDMOs, CROs, and consultants to connect directly with decision-makers shaping CGT manufacturing standards.

Unlike broader conferences, this Summit dives deep into the materials science, regulatory alignment, and supplier strategy that determine therapeutic success. With FDA, USP, and top biotechs such as Ultragenyx, Vertex and Abeona in the room, along with pharma giants such as Bristol Myers Squibb and Roche, this is where the future of CGT quality begins, and raw materials excel - making this your go-to partnership opportunity.

What Experts Need from You:

Single-Use Suppliers:
CGT developers are urgently seeking partners who can deliver high-quality, GMP-ready consumables with traceable, lot-specific data, helping them reduce variability, streamline audits, and accelerate regulatory approval

CDMOs:
Biotech leaders need agile CDMOs that don’t just manufacture - but collaborate. From raw material onboarding to late-stage scale-up, sponsors are looking for CDMOs who can drive speed, flexibility, and compliance across the CGT pipeline

CROs:
With regulatory scrutiny at an all-time high, CGT innovators are turning to CROs who can design and execute cutting-edge material testing strategies, ensuring safety, comparability, and confidence at every clinical stage

Consultants:
Manufacturers are looking for consultants who bring more than advice. They want proven, hands-on strategies to optimize raw material qualification, de-risk supply chains, and navigate complex global regulatory landscapes with clarity and speed

Why Partner with the Summit?

Establish Your Brand as a Raw Materials Thought Leader

Position your organization at the forefront of one of the most complex and rapidly evolving areas in CGT. Through speaking opportunities, panel involvement, and curated roundtables, you’ll elevate your visibility as a trusted partner in raw material innovation and compliance

Drive Qualified Pipeline Growth & Partnerships

This Summit is engineered for results, bringing together buyers and influencers with real purchasing power. Whether you're a supplier, CDMO, CRO, or consultant, you'll gain access to decision-makers ready to collaborate, co-develop, and source smarter for next-gen therapies

Access Focused Cell & Gene Therapy Raw Materials Audiences

Engage directly with decision-makers in MSAT, Quality, Supply Chain, and Regulatory Affairs who are actively shaping raw material strategies for clinical and commercial CGT pipelines. This is your opportunity to showcase solutions to biopharma stakeholders tasked with vendor qualification, testing, and risk mitigation

Who Will You Meet?

raw audience stats

Interested in partnering?
Get in touch to benefit from market intelligence, showcase your world-class solutions and forge valuable commercial collaborations.

“Raw materials and material qualification is an emerging field and knowledge sharing is key in the overall success of the cell and gene therapy space.  A lot of suppliers cannot support the needs of the cell and gene therapy raw material quality attributes and establishing a base line for everyone to be on the same page is the beginning” 

Sona Bairamian, Director, Materials Science, Atara Biotherapeutics 

Explore Related Events:

Hanson Wade is committed to bringing the cell and gene therapy spaces bespoke conferences catering for every niche, with the aim of getting better drugs to patients faster.

Take a look at our related events below to find out more about our tailored conferences, designed to put you in the room with decision makers from both leading and emerging companies in these growing spaces

55688 - 7th Allogeneic Cell Therapies Summit 2025
GTx Prospectus cover

Having trouble downloading the prospectus? Let us know here and we'll email it to you instead.